{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:21:53Z","timestamp":1747207313202,"version":"3.40.5"},"reference-count":27,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2020,12,29]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The antimicrobial resistance due to biofilm formation among bacteria is a\nsignificant problem in the healthcare and food industries.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The current study describes the synthesis of enrofloxacin derivatives 2-17, and the\nevaluation of their anti-bacterial and anti-biofilm activities.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Compounds 2-17 were synthesized through the acylation of enrofloxacin with thionyl\nchloride, followed by reaction with different aromatic amines. The new analogues identified among\nthe sixteen compounds were 2-7, 11, 14, and 17.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Compound 2 appeared to be effective against pathogens S. aureus as well as K. pneumonia,\nwhereas, compound 11 was found active against K. pneumonia only. Compound 2 inhibited &gt;75%\nbiofilm formation of S. aureus at 20 \u03bcg\/mL and K. pneumonia at 10 \u03bcg\/mL concentrations. These\ndoses are far below the bactericidal concentration of compound 2, suggesting the anti-virulence\nmechanism of these compounds. Compound 11 inhibited 60% biofilm formation of K. pneumoniae\nat 70 \u03bcg\/mL concentration. Compound 5 inhibited the biofilm of K. pneumoniae at 62 \u03bcg\/mL concentration\nbut also had bactericidal properties at this concentration. Interestingly, compound 2 eradicated\nthe preformed biofilm of both the pathogens at much lower doses as compared to control drug,\ngentamycin and substrate, enrofloxacin. Cytotoxicity of compounds 2\u201317 was checked by a standard\nmethod using 3T3 normal cell lines (mouse fibroblast), all compounds were found to be noncytotoxic.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>These compounds can be used alone or with FDA approved drugs to overcome biofilm\nrelated K. pneumoniae and S. aureus infections.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406416666200402151705","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T15:07:41Z","timestamp":1585840061000},"page":"85-96","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Synthesis of new Enrofloxacin Derivatives as Potential Antibiofilm Drugs Against Staphylococcus Aureus and Klebsiella Pneumoniae"],"prefix":"10.2174","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0432-2237","authenticated-orcid":true,"given":"Hina","family":"Siddiqui","sequence":"first","affiliation":[{"name":"H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haroon M.","family":"Haniffa","sequence":"additional","affiliation":[{"name":"H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaz","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad I.","family":"Choudhary","sequence":"additional","affiliation":[{"name":"H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/jac\/46.5.669","volume":"46","author":"Wright D.H.","year":"2000","unstructured":"Wright D.H.; Brown G.H.; Peterson M.L.; Rotschafer J.C.; Application of fluoroquinolone pharmacodynamics. J Antimicrob Chemother 2000,46(5),669-683","journal-title":"J Antimicrob Chemother"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4236\/ojvm.2016.62006","volume":"6","author":"Trouchon T.","year":"2016","unstructured":"Trouchon T.; Lefebvre S.; A review of enrofloxacin for veterinary use. Open J Vet Med 2016,6(2),40-58","journal-title":"Open J Vet Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.rvsc.2007.04.007","volume":"84","author":"Aral F.","year":"2008","unstructured":"Aral F.; Kara\u00e7al F.; Baba F.; The effect of enrofloxacin on sperm quality in male mice. Res Vet Sci 2008,84(1),95-99","journal-title":"Res Vet Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1365-2885.1993.tb00212.x","volume":"16","author":"K\u00fcng K.","year":"1993","unstructured":"K\u00fcng K.; Riond J.L.; Wanner M.; Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. J Vet Pharmacol Ther 1993,16(4),462-468","journal-title":"J Vet Pharmacol Ther"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0003-2670(01)00925-4","volume":"437","author":"Watanabe H.","year":"2001","unstructured":"Watanabe H.; Satake A.; Kido Y.; Tsuji A.; Monoclonal-based enzyme-linked immunosorbent assay and immunochromatographic rapid assay for salinomycin. Anal Chim Acta 2001,437(1),31-38","journal-title":"Anal Chim Acta"},{"year":"2002","author":"Hern\u00e1ndez M.","key":"ref=6","unstructured":"Hern\u00e1ndez M.; Aguilar C.; Borrull F.; Calull M.;  2002"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/jhet.5570450343","volume":"45","author":"Mirzaei J.","year":"2008","unstructured":"Mirzaei J.; Pirelahi H.; Amini M.; Abbas Shafiee A.; Convenient syntheses of 5-[(2-methyl-5-nitro-1H-imidazol-1-yl) methyl] -1, 3, 4-oxadiazole-2 (3H) thione and N-substituted 2-amino-5- [(2-methyl-5-nitro-1H-imidazol-1-yl) methyl] -1, 3, 4-thiadiazoles. J Heterocycl Chem 2008,45(3),921-925","journal-title":"J Heterocycl Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3923\/ijbc.2011.37.45","volume":"5","author":"Patel N.B.","year":"2011","unstructured":"Patel N.B.; Patel S.D.; Patel J.N.; Patel J.C.; Gorgamwala Y.S.; Synthesis and antibacterial activity of thioureido amide of fluoroquinolone. Int J Biol Chem 2011,5(1),37-45","journal-title":"Int J Biol Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/cbdv.201400456","volume":"12","author":"Purkayastha N.","year":"2015","unstructured":"Purkayastha N.; Capone S.; Beck A.K.; Seebach D.; Leeds J.; Thompson K.; Moser H.E.; Antibacterial activity of enrofloxacin and ciprofloxacin derivatives of \u03b2-octaarginine. Chem Biodivers 2015,12(2),179-193","journal-title":"Chem Biodivers"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/ijms19010077","volume":"19","author":"Choi J.","year":"2017","unstructured":"Choi J.; Lee Y.M.; Jee J.G.; Thiopurine drugs repositioned as tyrosinase inhibitors. Int J Mol Sci 2017,19(1),77","journal-title":"Int J Mol Sci"},{"key":"ref=11","first-page":"239","volume":"143","author":"Abdel-Monem W.R.","year":"2004","unstructured":"Abdel-Monem W.R.; Synthesis and biological evaluations of sulfa derivatives bearing heterocyclic moieties. Boll Chim Farm 2004,143(6),239-247","journal-title":"Boll Chim Farm"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"Ashburn T.T.","year":"2004","unstructured":"Ashburn T.T.; Thor K.B.; Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 2004,3(8),673-683","journal-title":"Nat Rev Drug Discov"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.tips.2015.11.006","volume":"37","author":"Sisignano M.","year":"2016","unstructured":"Sisignano M.; Parnham M.J.; Geisslinger G.; Drug repurposing for the development of novel analgesics. Trends Pharmacol Sci 2016,37(3),172-183","journal-title":"Trends Pharmacol Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3389\/fmicb.2016.00592","volume":"7","author":"Miquel S.","year":"2016","unstructured":"Miquel S.; Lagrafeuille R.; Souweine B.; Forestier C.; Anti-biofilm activity as a health issue. Front Microbiol 2016,7,592","journal-title":"Front Microbiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1128\/MMBR.00041-08","volume":"73","author":"Karatan E.","year":"2009","unstructured":"Karatan E.; Watnick P.; Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mol Biol Rev 2009,73(2),310-347","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2174\/1389450120666181123123333","volume":"20","author":"Khan F.","year":"2019","unstructured":"Khan F.; Javaid A.; Kim Y-M.; Functional diversity of quorum sensing receptors in pathogenic bacteria: Interspecies, intraspecies and interkingdom level. Curr Drug Targets 2019,20(6),655-667","journal-title":"Curr Drug Targets"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/21505594.2017.1313372","volume":"9","author":"Roy R.","year":"2018","unstructured":"Roy R.; Tiwari M.; Donelli G.; Tiwari V.; Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action. Virulence 2018,9(1),522-554","journal-title":"Virulence"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/343560","volume":"2013","author":"Tarr J.M.","year":"2013","unstructured":"Tarr J.M.; Kaul K.; Chopra M.; Kohner E.M.; Chibber R.; Pathophysiology of diabetic retinopathy. ISRN Ophthalmol 2013,2013","journal-title":"ISRN Ophthalmol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s00284-009-9563-z","volume":"60","author":"Wang X.","year":"2010","unstructured":"Wang X.; L\u00fcnsdorf H.; Ehr\u00e9n I.; Brauner A.; R\u00f6mling U.; Characteristics of biofilms from urinary tract catheters and presence of biofilm-related components in Escherichia coli. Curr Microbiol 2010,60(6),446-453","journal-title":"Curr Microbiol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.7860\/JCDR\/2012\/4367.2537","volume":"6","author":"Niveditha S.","year":"2012","unstructured":"Niveditha S.; Pramodhini S.; Umadevi S.; Kumar S.; Stephen S.; The isolation and the biofilm formation of uropathogens in the patients with catheter associated urinary tract infections (UTIs). J Clin Diagn Res 2012,6(9),1478-1482","journal-title":"J Clin Diagn Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jiph.2016.08.007","volume":"10","author":"Frieri M.","year":"2017","unstructured":"Frieri M.; Kumar K.; Boutin A.; Antibiotic resistance. J Infect Public Health 2017,10(4),369-378","journal-title":"J Infect Public Health"},{"key":"ref=22","first-page":"43","volume":"7","author":"Navidinia M.","year":"2016","unstructured":"Navidinia M.; The clinical importance of emerging ESKAPE pathogens in nosocomial infections. J Paramed Sci 2016,7(3),43-57","journal-title":"J Paramed Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.20546\/ijcmas.2018.702.354","volume":"7","author":"Agrawal A.","year":"2018","unstructured":"Agrawal A.; Chaudhary U.; Effect of natural compounds on inhibition of biofilm formation of multi drug resistant Staphylococcus aureus and Staphylococcus epidermidis-an in vitro Study. Int J Curr Microbiol Appl Sci 2018,7(2),2921-2926","journal-title":"Int J Curr Microbiol Appl Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ejmech.2017.06.065","volume":"138","author":"Khan A.K.","year":"2017","unstructured":"Khan A.K.; Ahmed A.; Hussain M.; Khan I.A.; Ali S.A.; Farooq A.D.; Faizi S.; Antibiofilm potential of 16-oxo-cleroda-3, 13(14) E-diene-15 oic acid and its five new \u03b3-amino \u03b3-lactone derivatives against methicillin resistant Staphylococcus aureus and Streptococcus mutans. Eur J Med Chem 2017,138,480-490","journal-title":"Eur J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"Mosmann T.","year":"1983","unstructured":"Mosmann T.; Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983,65(1-2),55-63","journal-title":"J Immunol Methods"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2019.110627","volume":"185","author":"Khan F.","year":"2020","unstructured":"Khan F.; Pham D.T.N.; Oloketuyi S.F.; Manivasagan P.; Oh J.; Kim Y-M.; Chitosan and their derivatives: Antibiofilm drugs against pathogenic bacteria. Colloids Surf B Biointerfaces 2020,185","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012427","volume":"2","author":"Rutherford S.T.","year":"2012","unstructured":"Rutherford S.T.; Bassler B.L.; Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med 2012,2(11)","journal-title":"Cold Spring Harb Perspect Med"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/180677","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/180677\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/180677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T03:53:01Z","timestamp":1627617181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/180677\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,29]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12,29]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406416666200402151705","relation":{},"ISSN":["1573-4064"],"issn-type":[{"type":"print","value":"1573-4064"}],"subject":[],"published":{"date-parts":[[2020,12,29]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-09-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}